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Background: The literature suggests that research funding decisions may be influenced by criteria such as gender
or institution of the principal investigator (PI). The aim of this study was to investigate the association between
characteristics of funding applications and success when considered by a research funding board.
Methods: We selected a retrospective cohort of 296 outline applications for primary research (mainly pragmatic
clinical trials) submitted to the commissioning board of the National Institute for Health Research (NIHR) Health
Technology Assessment (HTA) Programme between January 1st 2006 and December 31st 2009. We selected
proposals submitted to the commissioned NIHR HTA work stream as they addressed issues which the programme
already deemed to be important, hence the priority of the research question was not considered as one of the
selection criteria for success or failure. Main outcome measures were success or failure at short-listing and in
obtaining research funding.
Results: The characteristics of applications associated with success at shortlisting and funding were multi-disciplinarity
of the team (OR 19.94 [5.13, 77.50], P <0.0001), particularly inclusion of a statistician (OR 3.76 [2.21, 6.37], P <0.0001),
and the completion of a pilot/feasibility study (OR 4.11 [1.24, 13.62], P = 0.0209). The gender of the PI was not associated
with success or failure at either stage. The PI’s affiliation institution was not associated with success or failure
at shortlisting.
Conclusions: The gender of the PI was not associated with success or failure. The characteristics of research
applications most strongly associated with success were related to the range of expertise in the team and
the completion of a pilot or feasibility study.
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For most researchers, the task of obtaining funding for re-
search is a vital and constant part of their working lives.
The importance of writing a good application and select-
ing an appropriate funding body [1-6] has long been
understood. Some of the issues relating to obtaining re-
search funding, such as the aims of funding organisations
[7-10], their policies [11,12], priorities [10,13,14], pro-
cesses [10,15], and value for money [16-19], have previ-
ously been examined.
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unless otherwise stated.internationally [20-22]. It is in the interests of the fund-
ing organisations, researchers, and society in general
that there is a transparent and fair way of selecting
the best applications from those received. However, it is
not always clear if the system is operating in the way
intended, or if there may be unintentional outcomes in
the system [23].
Previous analysis conducted over the last 10 to 12
years (mainly in the USA), suggests that in medical and
biomedical research criteria, such as gender [24-27] or
institution [28] of the principal investigator (PI) and the
amount of funding available [29], may have an influence
on success or failure in obtaining funding. Some previ-
ous studies of medical research have found a gender dis-
parity in terms of the numbers of applications received
from male and female PIs [24,26,27,30], the amountsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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was related to seniority [24,26,30,31] and qualifications
[25,32] of the applicants, which were both associated
with gender [24,25,27,33,34]. However, a large meta-
analysis considering gender differences in peer review of
grant applications across a range of disciplines [35], and
a later study [36], found no gender differences.
In view of the uncertainty about the current prefer-
ences of funding committees, this study aims to investi-
gate the association between characteristics of funding
applications and success in obtaining funding from one
research funding organisation, the National Institute for
Health research (NIHR) Health Technology Assessment
(HTA) Programme, which was established in the UK in
1993. The NIHR HTA Programme funds a large number
of late phase clinical trials and complex evidence synthesis
studies investigating the clinical and cost effectiveness of a
diverse range of interventions which may include drugs,
devices, physical therapies, talking therapies, preventative
interventions, surgical procedures, and tests. Because the
NIHR embraces the principles of Athena Swan [37], we
wished to investigate whether there was any disparity with
regard to gender. From an informal examination of UK re-
search council websites, the host institutions of their ap-
plicants and those applying to the NIHR HTA programme
are broadly similar. We therefore anticipate that the re-
sults of this study will be useful to researchers preparing
applications to this and similar funders and to research
funders who may wish to improve funding systems.
Methods
We undertook a retrospective cohort study of funding ap-
plications submitted to the NIHR HTA Commissioning
Board, a committee of just over 20 independent senior
academic clinicians and methodologists, selected for their
experience in carrying out high quality health research.
The board considers only commissioned research applica-
tions in which the research question is decided by the
funding organisation, which advertises for applications for
studies to answer the detailed research question specified.
This advertisement includes a commissioning brief that
gives details relating to the research question, participants,
intervention, comparator, and outcome measures, as well
as the suggested study type. The remit of the NIHR HTA
Programme is described on the website [38]. This funding
mode is in contrast to response-mode funding where re-
searchers are free to submit applications on topics chosen
by them. We used commissioned research so that we
could examine generic factors in the teams and their ap-
plications, without having to take account of the import-
ance of the topic they were proposing to investigate, as
the topic had already been deemed important by the
funder. Applications in response to a particular commis-
sioning brief were in direct competition with each other,and funding decisions made on the quality of the applica-
tion alone, as other variables such as research question
and study outline framework had been indicated by the
brief.
Funding board processes
The funding process for the NIHR HTA programme com-
prises two stages. At the first stage, outline applications
are considered by the board and the most promising are
selected (or shortlisted) to submit a full application for
further review by the board before a decision on which, if
any, of the applications submitted should be funded. Com-
ments on the quality of the application including adher-
ence to the brief are formally noted. At the second stage,
funding decisions are made after external peer review and
subsequent consideration of the full applications by the
board. At the outline stage, it is usual practice for the
board to offer advice which is fed back to shortlisted appli-
cants in order to improve the quality of the subsequent
full application in light of these comments.
Eligibility and sample size
Eligible applications were outline applications for pri-
mary research submitted to the Commissioning Board of
the NIHR HTA programme from January 1st 2006 to
December 31st 2009. Where no applications were short-
listed for a particular commissioning brief all data relat-
ing to that brief were excluded from the study. We also
excluded from the study any outline proposals which the
funding board asked to be resubmitted, and any applica-
tions received from countries not eligible for funding
(Figure 1).
Only outline applications were included in this study
as we wished to examine the applications as they were
originally submitted by the researchers, before input
from the board, to gain insight into which characteristics
are predictive of success.
We selected the sample size to provide at least 10
events (in our case 10 applications funded) for each of 8
characteristics selected [39] (Table 1). Prior to starting
the study we noted that there were 347 applications re-
ceived by the NIHR HTA programme between January
1st 2006 and December 31st 2009 providing an adequate
number of events. The study was not powered for the
exploratory analysis of secondary characteristics, though
these were adjusted for in the primary analysis.
Selection of characteristics
We conducted a literature search which identified research
which suggested that criteria such as gender or the institu-
tion for the PI or skill mix for the team may have an influ-
ence on funding decisions. Medline, Health Management
Information Consortium database, and CAB abstracts
were searched via OVID (limits: English language,
Figure 1 Flowchart showing flow of applications through application and funding process and numbers of applications included in
statistical analysis.
Table 1 Characteristics recorded
Characteristics on which study was powered
1 Gender of PI
2 Institution for PI
3 Number of co-applicants on application
4 Named statistician on application as a PI or co-applicant
5 Named clinician on application as a PI or co-applicant
6 Multi-disciplinarity of team – 2 or more out of:
i) Health economist on application as a PI or co-applicant,
ii) Clinician with NHS responsibilities on application as a
PI or co-applicant
iii) Social Scientist or Psychologist on application as a PI
or co-applicant,
iv) Methodologist on application as a PI or co-applicant
7 Has there been a pilot/feasibility study?
8 Has the PI or team led or participated in a relevant
systematic review?
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grant, proposal, research bid, clinical trial, success; date of
last search February 2012). The findings from the literature
search were discussed by an external expert advisory group
(please see acknowledgements). The characteristics of the
applications to be recorded were selected a priori after this
consultation process. Characteristics were selected in order
to test hypotheses; we hoped that some of the charac-
teristics, such as gender and institution for the first appli-
cant would not influence outcome, whereas characteristics
which might be expected to be associated with success in-
cluded the composition of the team and whether or not a
pilot or feasibility study had been completed. For a list of
characteristics selected see Table 1.
In the UK, universities from the Russell Group ‘which
are committed to maintaining the very best research’
[40], have received a high proportion of funding from re-
search councils. In 2008/2009, Russell Group universities
accounted for 68% (over £1.0 billion) of total income
from the Research Councils [40]. Of the 20 (at the time
of this cohort) Russell Group universities, six (known
informally as the big six [THE 9/12/2010 http://www.
timeshighereducation.co.uk/418215.article]) have been
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We examined whether having a first applicant from
these groups was associated with application success.
We also selected other characteristics for adjustment in
our model. These included clinical trials unit (CTU) in-
volvement, total research costs and whether the study was
multi-centred (which could be related to larger teams),
history of NIHR HTA funding or NIHR HTA board mem-
bers included on the application, both markers of expert-
ise and experience, and whether the application met the
brief and whether the form was filled in badly.
Data extraction for selected characteristics
We extracted data relating to the selected characteristics
(Table 1) of outline applications for primary research
from paper files and recorded them in an MS Access
database. A chart showing the flow of applications
through the funding process is shown in Figure 1. We
recorded data for most fields as yes or no and some as
yes, no, or unclear. We categorised institution for the first
applicant into three groups by research intensity: i) the
big six (Universities of Cambridge, Edinburgh, Oxford,
Manchester, Imperial College London, and University
College London); ii) Russell group other than the big
six (Universities of Birmingham, Bristol, Cardiff, Glasgow,
Leeds, Liverpool, Newcastle, Nottingham, Sheffield,
Southampton, Warwick, Kings College London, London
School of Economics, and Queen’s Belfast); and iii) other
universities.
We inferred gender of first applicant from their full
name and title. Information as to whether or not the first
applicant had previous NIHR HTA funding and whether
any of the applicants were current or past board members
at the time of submitting the application, was available
from programme electronic records. We assessed adher-
ence to the advertised commissioning brief from the writ-
ten reports of the board. Whether the form was filled in
badly was a judgement made considering numbers of
spelling mistakes and typographical errors and how diffi-
cult it was to read the information presented. We cate-
gorised research cost into £500,000 bands.
We recorded two outcomes of interest: i) success at
first stage of the application process where an outline
proposal is assessed (short-listing) and ii) eventual suc-
cess in obtaining funding, the final stage, in which a full
proposal is seen by the board. Data regarding the first,
success at the short-listing stage, was recorded in paper
files; for the second, success in obtaining funding, we
obtained data from electronic records.
One researcher (ST) initially performed the data ex-
traction. Subsequently 30 (10%) of the applications were
selected randomly and checked for accuracy by a second
researcher (ES). Where it was unclear whether an appli-
cation fulfilled a particular characteristic, differenceswere discussed by the team and decisions reached col-
lectively. Of the 30 applications randomly selected and
checked for accuracy, no discrepancies were found in 20
of the 24 fields (which included fields for factors for ad-
justment). A total of 8 discrepancies were found within
only 4 fields [whether the team had lead or participated in
a systematic review (2), methodologist (2), history of
NIHR HTA grants (1), and CTU involvement (3)]. As the
number of discrepancies was so low no further checks
were made. The discrepancies were limited to those fea-
tures that were open to interpretation, for instance, the
disciplines of the applicants were sometimes not clear
from job titles as an indication of specialism. We dis-
cussed uncertainties in these fields on a case by case basis
and decisions were reached collectively within the re-
search team. In the majority of cases where data extrac-
tion on the prior conduct of a pilot study or systematic
review by the applicants was attempted, data were miss-
ing, so we recorded the characteristic as unclear.
Whether the form was filled in badly was a subjective
judgement, however, as the data extraction was initially
done by one researcher there was consistency within the
sample. We only considered an application as badly com-
pleted if it contained multiple typographical errors or was
laid out so poorly as to undermine confidence in the
authors.
Univariate and multivariate statistical analysis
We performed all analyses in STATA version 11.0. For
the outcome “success at shortlisting” we excluded applica-
tions from the analysis if for a particular commissioning
brief all the applications were shortlisted because they
contributed nothing to knowledge about why one applica-
tion for a brief was selected over another (Figure 1). For
the same reason, for outcome “success obtaining funding”
we excluded proposals from the analysis if either all the
applications for a commissioning brief were funded or all
were not funded (Figure 1). We fitted several regression
models [39,41-43] to test whether the selected characteris-
tics were associated with an application being shortlisted
or funded.
To do this, we used conditional logistic regression model-
ling instead of ordinary logistic regression because the data
were clustered. A number of applications are received for
each advertised commissioning brief and, of those, only one
can be funded. In addition, the characteristics of the appli-
cations received for the same commissioning brief were
likely to be correlated and were therefore not independent.
We took account of this clustering allowing for intra-group
correlation using the vce(cluster) option in STATA (the
usual requirement that the observations be independent
was relaxed). We considered observations (applications) to
be independent across groups (commissioning briefs) but
not necessarily within groups (as applications within groups
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in competition with each other).
To identify the characteristics most strongly associated
with the application being shortlisted/not shortlisted and
funded/not funded we used a backward and forward
stepwise elimination process and Akaike information cri-
teria to decide which characteristics were kept in the
final model (as recommended by Royston et al. [39]).
Akaike information criterion is a measure of model fit
that includes a penalty against large models and hence
attempts to reduce overfitting. For a single predictor, the
criterion equates to selection at 15.7% significance [39].
We also fitted a full model, and compared the results to
the models obtained from backwards and forwards selec-
tion methods. No interactions between characteristics
were considered for inclusion in the models.
Results
The number of outline proposals for primary research
submitted to the NIHR HTA programme between January
1st 2006 and 31st December 2009 was 347 (Figure 1). One
was ineligible for funding under the regulations of the
programme. Of the remainder, 47 were in calls for which
none of the proposals were shortlisted and 3 were asked
to resubmit outline proposals; we excluded these from the
analysis. This left a total of 296, from which we extracted
data. Overall, 129 out of the 296 applications were short-
listed (43.6%) and 60/296 were funded (20%). The data are
summarised in Table 2.
Initial scoping, however, had not included the detailed
examination of linked applications that were all rejected
or funded and, therefore, non-contributory to the ana-
lysis. Because such linked events were non-contributory,
only 53 of the 90 events contributed to the multivariate
analyses on the outcome of being funded. We followed
our pre-specified analysis plan for both shortlisted and
funded and have presented the results of both in this
publication.
Univariate and multivariate statistical analysis
1) Analysis at shortlisting stage (Table 2)
Statistical analysis data for particular commissioning
briefs where shortlisting outcomes were all positive were
excluded (n = 39). Out of the 257 applications included
in the analysis, 90 were shortlisted (35%). In the univari-
ate analysis, the characteristics of the applicants posi-
tively associated with success at the first (shortlisting)
board were having a named statistician, having a multi-
disciplinary team, larger teams with four or more appli-
cants, and the completion of a pilot/feasibility study. There
was no association with gender or institution of the first
applicant, or with their participation in a systematic review.In the full model, multidisciplinarity of the team remained
a significant association after adjustment, as did comple-
tion of a pilot or feasibility study. The association with
larger teams did not remain after adjustment for other fac-
tors; however, this characteristic is related to multidiscipli-
narity. In the full model, neither the gender of the first
applicant, nor the status of their institution was signifi-
cantly linked to success at the board. The characteristics
selected to be kept in the model from the forwards and
backwards model selection process indicate the character-
istics most strongly associated with success are presence
of a named statistician on the application, multidiscipli-
narity of the team, and pilot/feasibility study completed.
We considered that previous research in a topic area
by a formal systematic review would lead to better appli-
cations and be associated with success. We did not find
a significant association with this but were limited by
the small number of applications building on previous
research. This should perhaps have been anticipated be-
cause the research questions were set by the funder, so
most applicants were coming to the topic without the
opportunity to undertake preliminary work.
2) Analysis at funding stage
Data for particular commissioning briefs where funding
outcomes were either all positive or all negative for a
commissioning brief (n = 21) were excluded from the stat-
istical analysis because they contributed no useful data to
the analysis; 60 out of the 236 applications included in the
statistical analysis were funded. The success of the full ap-
plication in obtaining funding at the second board was
not the focus of this study. The funding decision is made
on what is essentially a different application, which is sub-
mitted after input from the shortlisting board, potentially
correcting deficiencies in the original application so these
results should be interpreted with caution. The full model
showed positive associations with having a named statisti-
cian, multidisciplinarity of the team, and the completion
of a pilot or feasibility study. Larger teams with more than
four applicants showed a negative association with fund-
ing. This result is unexpected and is possibly due to very
low numbers of applications with small teams of appli-
cants. Similarly, having participated in a systematic review
and institution, being Russell Group excluding the big six,
are also negatively associated with success. These results
could also be due to low numbers in the model.
Discussion
The main outcome of interest in this study was success
at the first (shortlisting) stage where the outline applica-
tions are considered unmodified and without the board’s
feedback. We examined features of the applications, de-
termined a priori by our expert advisory group, that we
Table 2 Results from conditional logistic regression modelling
Shortlisting results Shortlisting model results Funding model results
Application
characteristic






















Statistician 164 (63.8%) 73 (81.1) 91 (54.5) 3.76 (2.21, 6.37)* <0.0001 2.31
(0.97, 5.50)
2.25 (1.08, 4.68)* 6.20 (1.73, 22.27)* 6.23 (1.60, 24.28)*





205 (79.8%) 88 (97.8) 117 (70.1) 19.94 (5.13, 77.50)* <0.0001 17.28
(2.59, 115.32)*




237 (92.2) 89 (98.9) 148 (88.6) 11.17 (1.36, 91.59)* 0.0246 0.44
(0.01, 14.92)
0.08 (0.01, 0.83)* 0.08 (0.01, 0.71)*
Pilot/feasibility
study completed
Yes 10 (3.9%) 5 (5.6) 5 (3.0) 4.11 (1.24, 13.62)* 0.0209 14.76
(1.28, 169.89)*




No1 44 (17.1%) 16 (17.8) 28 (16.8) 1.0 1.0 1.0





22 (8.6%) 11 (12.2) 11 (6.6) 1.63 (0.70, 3.78) 0.2590 0.37
(0.10, 1.35)
0.21 (0.05, 0.81)* 0.29 (0.09, 1.00)
PI gender Male 165 (64.2%) 58 (64.4) 107 (64.1) 0.73 (0.39, 1.36) 0.3195 1.30
(0.54, 3.13)
0.47 (0.09, 2.40)
PI Institution Big 6 47 (18.3%) 16 (17.8) 31 (18.6) 1.10 (0.54, 2.22) 0.1223 1.32
(0.44, 3.90)
0.91 (0.27, 3.03) 0.93 (0.30, 2.89)
Russell Gp exc.
Big 6
103 (40.1%) 43 (47.8) 60 (35.9) 1.62 (1.00, 2.63)* 0.93
(0.41, 2.09)
0.04 (0.01, 0.26)* 0.08 (0.02, 0.39)*
Other1 107 (41.6%) 31 (34.4) 76 (45.5) 1.0 1.0 1.0 1.0
*a star is shown next to an odds ratio and 95% confidence interval if it is significant at the 5% level (e.g., confidence interval excludes 1).
1Reference category (for characteristics for which possible categories were Yes, No, or Unclear the No and Unclear group were combined prior to inclusion in the regression models).
2Odds ratio and 95% confidence interval associated with the model coefficients of characteristics kept in the model following the selection process (forwards and backwards selection methods gave the same model
so results for both have been presented in one column).
3Odds ratio and 95% confidence interval associated with the model coefficients from the model which included all characteristics.
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and a small number that we hoped would be unrelated
to outcome. Of the latter, it was encouraging to find that
the gender of the first applicant was not linked to suc-
cess at either stage. This result was in agreement with
the meta-analysis by Marsh et al., which investigated the
effect of gender differences on peer review for grant ap-
plications, over a wide range of disciplines in different
countries and found no difference [35]. Our result, like
that of Marsh et al., was contrary to some previous find-
ings, where being female may be disadvantageous in
obtaining research funding [26-29,32]. This difference
may partly be accounted for by differences in the type of
funding being sought, for example, the difference be-
tween personal fellowships and funding of projects
undertaken by multidisciplinary teams. The status of the
first applicants’ institution did not predict success either.
We considered that applications from the most research
intensive universities might be more successful; however,
the fact that this was not so may reflect a wide distribu-
tion of good research skills and that many teams are col-
laborations between institutions. We were only able to
easily retrieve the institution of the first applicant, and
the teams are often made up from several institutions,
diluting any effect from the first applicants’ institution.
We did not find any evidence of favouring certain insti-
tutions, although over half of applications were from the
Russell Group. Characteristics associated with success
included those concerned with the multi-disciplinarity,
particularly if the team included a statistician, and the
completion of a pilot or feasibility study. The number
of co-applicants is likely to be related to the multi-
disciplinarity of the team [44]. In order for the comple-
ment of the team to include expertise in all relevant
areas, proposals have to have a minimum number of
collaborators which could explain why, in univariate ana-
lyses, applications with four or fewer applicants were less
successful.
This study has several strengths; it was conducted
using a data set from a large and established research
funding programme, with continuity of process, covering
a four year period. It benefited from the external advis-
ory group who selected the characteristics in advance of
the data extraction and analysis. Importantly, we were
able to use a ‘commissioned research’ board to reduce
the unknown confounding effect of the importance of
the research question as a predictor of success since ap-
plicants were competing head to head to investigate the
same question.
Interpretation is constrained by some limitations of
the study. The study had only sufficient power to assess
some of our parameters, even at the first assessment
stage. We appropriately made the first stage of the appli-
cation process our focus, where the outline form is beingdirectly assessed, but limitation of the study was that we
did not include an examination of the full applications.
It would have been beyond the scope of this study to ex-
tract the data and incorporate these into the analysis.
There may be a rather tenuous relationship between the
initial application and the modified, often greatly improved,
full proposal, and the lack of power due to only 60 studies
being funded, means that we may have missed important
predictors of success at the final funding board. This study
examines one funding programme, using one dataset. The
results have not been validated in a second dataset. We be-
lieve that the NIHR HTA Programme is similar to other ap-
plied research funders in that it uses a two stage application
process assessed by committees and external peer review,
although we acknowledge that commissioned research is
rare. We suggest that our results are generalizable to other
funders of applied research, but we have not tested this.
Useful future research could include more detailed work
examining full applications, a similar study examining
researcher led applications, and a comparison looking
at other research funders.
Conclusions
Unlike previous reports from other research programmes,
there was no evidence of an applicant’s gender or the sta-
tus of their institution influencing the success of their ap-
plication. This may reflect a more positive effort on behalf
of the NIHR to ensure equal opportunities in line with
the principles of Athena Swan. The characteristics most
strongly associated with success are related to the range of
expertise in the team, and the completion of previous pilot
or feasibility study, and funding applicants could usefully
take this into account.
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